当代的管理范式和新兴的治疗方法用于骨髓质疏松症候群/新生体
Ramkarthic Ramanathan1, Yiyu Xie1, Talha Badar2
1Department of Medicine-Division of Hematology/Oncology, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts, USA.
British journal of haematology
|April 30, 2025
概括
基因组测序的最新进展正在彻底改变骨髓质疏松综合征 (MDS) 治疗. 除了传统药物之外,新疗法正在出现,改善了低风险和高风险MDS患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 基因组学就是基因组学.
背景情况:
- 从历史上看,肌肉发育综合征 (MDS) 的治疗环境已经获得了有限的FDA批准.
- 综合基因组测序的近期进展显著改善了我们对MDS生物学的理解.
研究的目的:
- 描述当代治疗选择如何改变MDS管理范式.
- 讨论试验性疗法及其对低风险和高风险MDS的潜在影响.
- 突出将新兴疗法转化为临床实践的挑战和解决方案.
主要方法:
- 对当代MDS治疗方法的里程碑式试验数据的审查.
- 讨论包括venetoclax,emavusertib,canakinumab和olutasidenib在内的试验性疗法.
- 分析基因组学,特别是TP53突变在MDS治疗中的作用.
主要成果:
- 新兴疗法为MDS提供了超越传统药物的新治疗途径.
- 了解MDS基因组学,包括TP53突变,对于治疗设计至关重要.
- 生物标志物识别可以指导临床试验设计和患者选择.
结论:
- 现代治疗正在重塑低风险和高风险MDS的管理.
- 进一步的研究和多中心随机试验对于新型MDS疗法的临床推出至关重要.
- 将基因组洞察力转化为有效的疗法是推动MDS护理的关键.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


